Margaret Helms - CardioComm Solutions Director
| EKGGF Stock | USD 0.01 0.00 0.00% |
Director
Ms. Margaret Helms serves as Director of the Company. Ms. Helms is a veteran mergerandacquisition professional with over 25 years of executivelevel experience in business transactions. These include publicly traded and privately held acquisitions, divestitures, equity investments and IP licensing, as well as distribution, supply and copromotion agreements. Her deals have spanned the globe, including China, Israel, Mexico and the European Union. Ms. Helms extensive record of completed global transactions includes medical devices, pharmaceuticals, biologics and health information technologies. As the president and founder of Morgan Wallace Associates, a global strategic health care MA consulting firm focused on smalltomidcap companies, Ms. Helms works with private equity firms, medical startup companies and medical device inventors who are seeking licensees andor strategic partners. Prior to Morgan Wallace Associates, Ms. Helms spent 31 years with Johnson Johnson. During this time, she was responsible for new business development, closing dozens of MA transactions and contributing to a cumulative business unit revenue growth of over 500million. She is particularly skilled at handling complex global acquisitions, most recently in Israel and China. Ms. Helms holds an MBA from Washington University in St. Louis and a BA from Rutgers University in New Brunswick, N.J. She is a member of the professional Licensing Executives Society, the Healthcare Businesswomen Association and the Women Business Leaders in Healthcare since 2016.
| Tenure | 8 years |
| Phone | 416 977 9425 |
| Web | https://www.cardiocommsolutions.com |
CardioComm Solutions Management Efficiency
The company has return on total asset (ROA) of 0.164 % which means that it generated a profit of $0.164 on every $100 spent on assets. This is way below average. CardioComm Solutions' management efficiency ratios could be used to measure how well CardioComm Solutions manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Michele Aronvald | SCOR PK | 57 | |
| Gerard Andreck | SCOR PK | 71 | |
| Claude Tendil | SCOR PK | 72 | |
| Peter Eckert | SCOR PK | 70 | |
| Daniel Valot | SCOR PK | 70 | |
| JeanMarc Raby | SCOR PK | 59 | |
| Augustin Romanet | SCOR PK | 55 | |
| Guylaine Saucier | SCOR PK | 68 | |
| Bruno Pfister | SCOR PK | 59 | |
| Vanessa Marquette | SCOR PK | 46 | |
| Kevin Knoer | SCOR PK | 58 | |
| Wang Zhen | SCOR PK | 61 | |
| Marguerite BerardAndrieu | SCOR PK | 40 | |
| Jane WickerMiurin | SCOR PK | 59 | |
| Thierry Derez | SCOR PK | 60 | |
| Guillaume Sarkozy | SCOR PK | 64 | |
| Andreas Brandstetter | SCOR PK | 45 | |
| Thomas Saunier | SCOR PK | 51 | |
| Augustin Beaune | SCOR PK | 57 | |
| Vincent Foucart | SCOR PK | 39 | |
| Charles Gave | SCOR PK | 71 | |
Management Performance
| Return On Asset | 0.16 |
CardioComm Solutions Leadership Team
Elected by the shareholders, the CardioComm Solutions' board of directors comprises two types of representatives: CardioComm Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CardioComm. The board's role is to monitor CardioComm Solutions' management team and ensure that shareholders' interests are well served. CardioComm Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CardioComm Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Etienne Grima, CEO, Corporate Secretary, Director and Member of Audit Committee | ||
| William Smith, Independent Director | ||
| Robert Caines, Director | ||
| Yury Levin, Independent Director | ||
| Anne Burpee, CFO | ||
| David Newman, Independent Director | ||
| Simi Grosman, Director | ||
| Anatoly Langer, Chairman of the Board | ||
| John Overall, CFO | ||
| Margaret Helms, Director | ||
| Josee CPA, Chief Officer | ||
| Steven Benyo, Director | ||
| MSc CHE, Corp CEO | ||
| Simi MBA, Independent Director | ||
| John Foote, Director | ||
| Wendy Hsieh, CFO |
CardioComm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CardioComm Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | 0.16 | |||
| Profit Margin | 0.28 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 1.82 M | |||
| Shares Outstanding | 151.16 M | |||
| Shares Owned By Insiders | 37.74 % | |||
| Price To Sales | 1.62 X | |||
| Revenue | 682.51 K | |||
| Gross Profit | 734.6 K | |||
| EBITDA | 61.24 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CardioComm Solutions in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CardioComm Solutions' short interest history, or implied volatility extrapolated from CardioComm Solutions options trading.
Pair Trading with CardioComm Solutions
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CardioComm Solutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CardioComm Solutions will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to CardioComm Solutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CardioComm Solutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CardioComm Solutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CardioComm Solutions to buy it.
The correlation of CardioComm Solutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CardioComm Solutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CardioComm Solutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CardioComm Solutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in CardioComm Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the CardioComm Solutions information on this page should be used as a complementary analysis to other CardioComm Solutions' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for CardioComm Pink Sheet analysis
When running CardioComm Solutions' price analysis, check to measure CardioComm Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CardioComm Solutions is operating at the current time. Most of CardioComm Solutions' value examination focuses on studying past and present price action to predict the probability of CardioComm Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CardioComm Solutions' price. Additionally, you may evaluate how the addition of CardioComm Solutions to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |